Publication Name	World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID	128040
DOI	10.4292/wjgpt.128040
Country	Brazil

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Myths and facts about diet in metabolic dysfunction-associated steatotic liver disease—part II: Nutrition during incretin-based therapy
Manuscript Source	Invited Manuscript
All Author List	Sabrina Alves Fernandes and João Marcello Araujo-Neto
Funding Agency and Grant Number
Corresponding Author	Sabrina Alves Fernandes, Hepatology, Santa Casa de Porto Alegre Hospital Complex, Professor Annes Dias, 295, Porto Alegre 90020-090, Rio Grande do Sul, Brazil. sabrinaafernandes@gmail.com
Key Words	Metabolic dysfunction-associated steatotic liver disease; Incretins; Glucagon-like peptide-1 receptor agonists; Nutrition therapy; Sarcopenia; Weight loss; Dietary counseling
Core Tip	Incretin-based therapies are changing the management of metabolic dysfunction-associated steatotic liver disease, but their appetite-suppressing effect does not make nutritional care optional. Withdrawal trials show that weight and cardiometabolic benefits are not maintained after discontinuation, and that lifestyle intervention alone does not replace the drug's effect. This review proposes 11 literature-informed, risk-stratified practical recommendations (not formal guidelines) covering nutritional and body-composition assessment, individualized protein intake with progressive resistance training, micronutrient and bone monitoring, and dietary management of gastrointestinal adverse events, and argues that nutritional follow-up should be part of incretin-based care from the start of treatment.
Citation	Fernandes SA, Araujo-Neto JM. Myths and facts about diet in metabolic dysfunction-associated steatotic liver disease—part II: Nutrition during incretin-based therapy. World J Gastrointest Pharmacol Ther 2026; In press DOI: https://doi.org/10.4292/wjgpt.128040
PDF	128040-in-press.pdf

Received	2026-09-14 09:17
Peer-Review Started	2026-09-14 09:17
First Decision by Editorial Office Director
Return for Revision	2026-09-23 14:09
Revised	2026-10-07 23:25
Publication Fee Transferred
Second Decision by Editor	2026-11-09 06:09
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2026-11-09 11:30
Articles in Press	2026-11-09 11:30
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	2150-5349 (online)
Open Access	This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright	©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com